- Home
- FDMT vs IBEX Comparison
FDMT vs IBEX Comparison
Compare FDMT & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | IBEX |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.4M | 489.1M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FDMT | IBEX |
|---|---|---|
| Price | $7.98 | $38.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $34.29 | $31.33 |
| AVG Volume (30 Days) | ★ 747.3K | 92.5K |
| Earning Date | 02-27-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.76 |
| EPS | N/A | ★ 2.77 |
| Revenue | $120,000.00 | ★ $579,735,000.00 |
| Revenue This Year | $21,227.03 | $12.15 |
| Revenue Next Year | $161.87 | $5.68 |
| P/E Ratio | ★ N/A | $13.96 |
| Revenue Growth | ★ 605.88 | 12.86 |
| 52 Week Low | $2.24 | $21.20 |
| 52 Week High | $12.34 | $42.99 |
Technical Indicators
Market Signals| Indicator | FDMT | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 57.27 |
| Support Level | $7.30 | $37.02 |
| Resistance Level | $7.80 | $38.72 |
| Average True Range (ATR) | 0.53 | 1.22 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 55.27 | 83.31 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.